File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

유자형

Ryu, Ja-Hyoung
Supramolecular Nanomaterials Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Biodegradable Mesoporous Organosilica Nanoparticle Drug Delivery Platform with universal targeting Protein affibody

Author(s)
Yang, GyeongsseokRyu, Ja-Hyoung
Issued Date
2021-10-22
URI
https://scholarworks.unist.ac.kr/handle/201301/76819
Fulltext
http://www.polymer.or.kr/english2/sub1/PaperDetail.php?pid=36303
Citation
The 2021 Annual Fall Meeting of Polymer Society of Korea
Abstract
The usage of protein corona shielded nanoparticles (PCSNs) as a nanocarrier is effective targeting drug delivery platform. However, the investigation of the controlled drug release profile of PCSN platform inside the cancer cell is still challenging for the perfection of the drug delivery. Here, the stimuli-responsive and biodegradable mesoporous organosilica nanoparticles (MONs) can be reduced by the GSH from the tumor microenvironment and degraded achieving better release than the conventional mesoporous silica nanoparticles (MSNs). The degradation can occur higher amount of the delivery of the drug, leading to the effective cancer cell death than the MSNs. Not only enhancing the release profiles, but the platform is also expected to achieve universality of the protein modification, with various kinds of the protein-affibody. Depending on the type of protein affibody of the nanoparticle, the cancer cells with certain overexpressed receptors could be targeted respectively.
Publisher
The polymer society of Korea

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.